Dutch Pharma Stock News

ING Groep highlighted rising risks for companies from higher funding costs in the private credit market. The bank pointed to concentrated exposure in the software sector as a key area of concern. ING also flagged increased inflation risks linked to geopolitical tensions as a pressure point for borrowers. For investors tracking ING Groep (ENXTAM:INGA), this risk signal comes with the shares trading around €22.315 and a 5 year return of 202.4%. The stock has seen a 27.4% gain over the past...

Aperam (ENXTAM:APAM) has been added to the Brussels BEL 20 Index, a move that can draw fresh attention from index trackers and benchmarked funds that allocate capital based on index membership. See our latest analysis for Aperam. Aperam's latest share price of €35.66 comes after a 1 day share price return of 1.77% and a 7 day share price return of 2.77%. Its 30 day share price return of an 18.02% decline contrasts with a 1 year total shareholder return of 19.05%, suggesting recent momentum...

Wolters Kluwer (ENXTAM:WKL) has launched Libra, its AI-powered legal workspace, in the Czech Republic, Slovakia, Hungary, and Romania. This rollout completes the company’s Eastern European deployment of Libra and follows its earlier acquisition of Libra Technology. The platform is designed to help legal professionals integrate generative AI into everyday workflows while supporting compliant use of legal data. For you as an investor, this move sits squarely in Wolters Kluwer’s core business...

Theon International (ENXTAM:THEON) has just shifted indices, exiting the Netherlands ASCX Small Cap Index and entering the AMX Index. This move can reshape how index funds and institutional investors approach the stock. See our latest analysis for Theon International. The recent index switch comes after a mixed price pattern, with a sharp 7 day share price return of a 14.87% decline contrasting with a 9.77% year to date share price gain and a 30.71% 1 year total shareholder return. This hints...

Recent performance snapshot for ArcelorMittal ArcelorMittal (ENXTAM:MT) has drawn attention after recent share price swings, with the stock up 1.9% over the past day and 1.1% over the past week, but showing an 18.4% decline over the past month. See our latest analysis for ArcelorMittal. That recent 18.4% one month share price return decline comes after a stronger run, with the year to date share price return at 15.6% and the 1 year total shareholder return at 62.0%. Momentum has cooled even...

Magnum Ice Cream disclosed recent acquisitions and disposals of ordinary shares by senior executives classified as PDMRs under EU and UK Market Abuse Regulation. The transactions, involving management directly linked to key decision making, have been formally notified and published as required for market transparency. The disclosures highlight changes in insider holdings at Magnum Ice Cream at a time when its shares last closed at €12.63 under ticker ENXTAM:MICC. For investors watching...

SK Hynix has placed a record €7.9b order for ASML's EUV lithography tools. The deal is described as the largest disclosed equipment purchase by any ASML customer. The order secures capacity for next generation memory and AI oriented chip production over multiple years. For investors watching ENXTAM:ASML, this order highlights how central the company has become to cutting edge chip manufacturing. The stock trades at around €1,211.6 and has returned 22.8% year to date and 86.0% over the past...

Basic-Fit (ENXTAM:BFIT) outlined full year 2026 revenue guidance in the range of €1.64b to €1.69b during its 2025 earnings call, giving investors fresh information on expected scale and growth plans. See our latest analysis for Basic-Fit. The share price reacted on the day, with a 1 day share price return of 4.63%, while the 90 day share price return of 7.97% sits alongside a 1 year total shareholder return of 63.31%. This suggests momentum has been building after weaker 3 and 5 year total...

Why InPost’s latest earnings and auditor warning matter for shareholders InPost (ENXTAM:INPST) is in the spotlight after reporting 2025 results that pair higher sales with sharply lower profits, alongside an auditor warning about its ability to continue as a going concern. That combination, together with management’s guidance for further revenue growth in 2026, leaves you weighing a business that is still growing its parcel locker footprint against fresh questions about financial resilience...

Index inclusion puts HAL Trust in focus HAL Trust (ENXTAM:HAL) has been added to the FTSE All-World Index (USD), an event that can alter trading patterns as index funds and passive products adjust their holdings. For existing and potential shareholders, the inclusion raises practical questions around liquidity, valuation, and how the stock’s recent return profile compares with increased index linked demand. See our latest analysis for HAL Trust. The index inclusion follows a period of strong...

Event overview and why ASM International is on investors’ radar ASM International (ENXTAM:ASM) has drawn investor attention after recent price moves, with the share price up around 2% over the past day but showing a 4% decline over the past month. See our latest analysis for ASM International. The recent 1-day share price return of 2.0% comes after a softer 30-day share price return of around a 4% decline. Longer term total shareholder returns of 49.8% over 1 year and 194.5% over 5 years...

On 19 March 2026, Flow Traders Ltd. launched a digital assets OTC offering that provides 24/7 proprietary, two-way liquidity for tokenized money-market funds, equities and commodities, including Franklin Templeton’s BENJI and Tether Gold, via its Digital Asset OTC platform. The move highlights how institutional investors are increasingly seeking round-the-clock access to tokenized instruments, using familiar OTC workflows, risk controls and connectivity across FIX, OMS/EMS platforms, ECNs...

Pharming Group (ENXTAM:PHARM) is back on investor radars after Japan’s Ministry of Health, Labour and Welfare approved Joenja for activated PI3K delta syndrome in patients aged 4 and older, including children 4 to 11. See our latest analysis for Pharming Group. The Joenja approval in Japan comes after a period where short term share price performance has been softer, with a 30 day share price return showing a decline of 1.21% and a year to date share price return showing a decline of 4.85%,...

On March 12, 2026, DSM-Firmenich AG announced a share repurchase program of up to €540 million, with €500 million earmarked for capital reduction and €40 million to satisfy share-based compensation, to be executed by a mandated bank and targeted for completion by the end of Q3 2026. This sizable buyback authorization signals the Board’s willingness to return cash to investors while tightening the share count, which can meaningfully influence ownership dilution from employee equity plans and...

Index removal puts Koninklijke Vopak (ENXTAM:VPK) in focus Koninklijke Vopak (ENXTAM:VPK) was removed from the FTSE All-World Index, a benchmark widely followed by institutional investors. This type of event can influence trading flows and how easily the stock appears on investor radars. See our latest analysis for Koninklijke Vopak. Despite the recent index removal and a 3.8% 7 day share price decline, Vopak’s 30 day share price return of 3.1% and 90 day gain of 21.8% sit alongside a 3 year...

This article examines whether Wolters Kluwer is attractively priced or still carries too much downside risk, by breaking down what the current share price might be implying about value. The stock last closed at €62.56, with returns of a 5.6% decline over 7 days, 0.3% over 30 days, a 28.9% decline year to date, and a 55.9% decline over 1 year. Many investors interpret this as a potential reset in expectations. Recent coverage has focused on how the share price performance contrasts with...

Event context and recent share performance Exor (ENXTAM:EXO) has drawn investor attention after a period of weaker share performance, with the stock showing a 1-day return decline of 1.85% and a past month return decline of 13.31%. See our latest analysis for Exor. At the current share price of €63.5, the stock’s weaker short term share price returns, including a 30 day share price decline of 13.31% and a year to date share price decline of 12.95%, align with a 1 year total shareholder return...

Ahold Delhaize USA CEO JJ Fleeman is set to step down in June 2026. The company has not yet named a successor for its U.S. operations. The transition affects one of the largest markets for Koninklijke Ahold Delhaize (ENXTAM:AD). Koninklijke Ahold Delhaize (ENXTAM:AD), trading at €40.53, sits at the center of a meaningful leadership change in its U.S. business. The company has seen returns of 16.2% year to date and 22.7% over the past year, with a 47.6% gain over three years and 102.0% over...

Wondering if ASML Holding at around €1,175 per share still makes sense for your portfolio, or if the price has run ahead of the fundamentals? The stock has had a mixed recent run, with a 1.8% decline over the past week and a 6.4% decline over the past month, while still showing a 19.2% gain year to date and a 75.8% return over the last year. Recent coverage has focused on ASML Holding's central role in supplying chipmaking equipment to major semiconductor producers and how that positioning...

SBM Offshore (ENXTAM:SBMO) has just moved into the Amsterdam AEX Index, shortly after its removal from the AMX. This shift often brings increased trading activity as index-tracking funds adjust their positions. See our latest analysis for SBM Offshore. The index change appears to have coincided with stronger momentum, with a 30-day share price return of 7.76% and a 90-day share price return of 35.75%, contributing to a 1-year total shareholder return of 75.83%. If this kind of index driven...

Akzo Nobel’s new bond issues and what they mean for shareholders Akzo Nobel (ENXTAM:AKZA) has launched two senior unsecured euro bond issues totaling €1.1b, offering 4% notes due 2031 and 4.625% notes due 2036. This is a funding move that directly affects its capital structure. See our latest analysis for Akzo Nobel. Despite the new bond issues, Akzo Nobel’s share price has been weak, with a 30-day share price return of 19.93% and a 1-year total shareholder return of 15.86%. This suggests...

Wolters Kluwer (ENXTAM:WKL) has been active on several fronts, from expanding AI powered tax research access for CPA Canada members to launching new cloud audit tools in Southeast Asia and extending key healthcare publishing partnerships. See our latest analysis for Wolters Kluwer. Despite the recent AI product launches, expanded healthcare publishing agreements and ongoing share buyback program, the stock’s 90 day share price return decline of 27.35% and 1 year total shareholder return...

Buyback announcement and what it could mean for DSM-Firmenich shares DSM-Firmenich (ENXTAM:DSFIR) has announced a share repurchase program of up to €540 million. Of this amount, €500 million is aimed at reducing issued capital and €40 million is reserved for share-based compensation commitments. See our latest analysis for DSM-Firmenich. At a share price of €58.12, DSM-Firmenich’s recent buyback announcement lands after a softer run, with a 30-day share price return of a 4% decline and a...

If you have been wondering whether Magnum Ice Cream at €12.88 is priced attractively or not, this article will walk through what that number could really mean for you as a shareholder. Over the short term, the share price has been soft, with a 4.6% decline over the last 7 days, a 4.4% decline over the last 30 days and a 3.1% decline year to date, which may change how investors think about both risk and opportunity. Recent coverage around consumer brands and listed food businesses has focused...